SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 362 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,424 | -20.6% | 20,000 | -25.0% | 0.01% | -15.4% |
Q2 2023 | $3,053 | +8.4% | 26,665 | +30.3% | 0.01% | +225.0% |
Q1 2023 | $2,817 | +207.2% | 20,457 | +189.0% | 0.00% | 0.0% |
Q4 2022 | $917 | -99.9% | 7,079 | +7.2% | 0.00% | +33.3% |
Q3 2022 | $729,000 | +1075.8% | 6,602 | +688.8% | 0.00% | – |
Q1 2021 | $62,000 | -56.3% | 837 | 0.0% | 0.00% | -100.0% |
Q4 2020 | $142,000 | -81.5% | 837 | -84.7% | 0.00% | -66.7% |
Q3 2020 | $769,000 | – | 5,478 | – | 0.00% | – |
Q2 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q1 2019 | $163,000 | -5.8% | 1,375 | -13.7% | 0.00% | 0.0% |
Q4 2018 | $173,000 | -32.4% | 1,594 | +0.3% | 0.00% | 0.0% |
Q3 2018 | $256,000 | +20.8% | 1,590 | -0.9% | 0.00% | 0.0% |
Q2 2018 | $212,000 | -70.5% | 1,605 | -83.5% | 0.00% | -66.7% |
Q1 2018 | $718,000 | +108.7% | 9,700 | +56.5% | 0.00% | +200.0% |
Q4 2017 | $344,000 | +65.4% | 6,200 | +34.8% | 0.00% | 0.0% |
Q3 2017 | $208,000 | -19.1% | 4,600 | +9.5% | 0.00% | 0.0% |
Q3 2016 | $257,000 | +8.9% | 4,200 | -16.0% | 0.00% | 0.0% |
Q3 2013 | $236,000 | +15.1% | 5,000 | -7.4% | 0.00% | 0.0% |
Q2 2013 | $205,000 | – | 5,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 290,000 | $44,066,000 | 9.14% |
Avoro Capital Advisors LLC | 1,400,000 | $212,730,000 | 7.35% |
NEXTHERA CAPITAL LP | 50,317 | $7,646,000 | 6.37% |
Eventide Asset Management | 1,123,000 | $170,640,000 | 5.19% |
RTW INVESTMENTS, LP | 604,236 | $91,814,000 | 4.90% |
Casdin Capital, LLC | 335,000 | $50,903,250,000 | 4.76% |
Copernicus Capital Management, LLC | 30,000 | $4,559,000 | 4.06% |
CADIAN CAPITAL MANAGEMENT, LP | 548,500 | $83,345,000 | 3.76% |
Dynamic Capital Management Ltd | 4,677 | $711,000 | 3.54% |
Camber Capital Management LP | 500,000 | $75,975,000 | 3.54% |